Treatment of community-acquired pneumonia typically involves either a respiratory fluoroquinolone or a combination of cephalosporin and a macrolide. Initial broad-spectrum antibiotic therapy should ...

Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. https://www.ncbi.nlm.nih.gov ...

Community-acquired pneumonia (CAP) is a common clinical disorder with an estimated incidence range from 1.6/1,000 to 16/1,000 per year. The ...

Severe community-acquired pneumonia should be treated with a respiratory fluoroquinolone or a combination of macrolides and β-lactams. Prior exposure to a specific antimicrobial in the past 3 months ...

Community-acquired pneumonia. This is a fancy way of saying you got infected somewhere other than a hospital or long-term care facility. Community-acquired pneumonia can be caused by bacteria ...

Mukanhaire, L., et al. (2023) Efficacy of corticosteroids as an adjunctive therapy in the treatment of community-acquired pneumonia: a systematic review and meta-analysis. Acta Materia Medica. doi ...

Community-acquired pneumonia (CAP) is a prevalent and potentially serious infectious disease, characterized by the development of lung infections in individuals who have not recently been ...

Pulmonology > Pneumonia Add-On Clarithromycin Pans Out in Community-Acquired Pneumonia Trial — Respiratory system severity scores, organ failure assessment scores improved, trial found ...

There are approximately 4 million cases of community-acquired pneumonia in the United States each year, resulting in about 1 million hospitalizations. 1–3 Inpatient management of pneumonia is ...

Background The etiologic profile of community-acquired pneumonia (CAP) for each age group could be similar among inpatients and outpatients. This fact brings up the link between etiology of CAP ...